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Our ideas about the management of
hypertension have changed considerably in recent years. There is now general agreement that all patients with
accelerated hypertension, as manifested by high diastolic pressure and
Group III and IV funduscopic
changes, should have their blood pressure reduced with antihypertensive
agents. Differences of opinion still
exist, however, in respect to the treatment of the less rapidly advancing
types of hypertension. It is apparent
that the life history of untreated essential hypertension varies widely
from those patients whose lives are
cut short in a matter of a few years,
to those who survive to old age. The
problem is further complicated because antihypertensive treatment is
neither simple, innocuous, or inexpensive.
If we are to approach a solution to
this problem we need to know the
answers to two questions. The first is:
Does antihypertensive treatment prevent the organic complications associated with hypertension? and the
second, How can we recognize and
differentiate the patient who will develop serious complications from the
patient who will live out a normal span
of life?
Is Therapy of Hypertension Necessary?

Let us consider first the question of
blood pressure reduction in preventing organic complications. The evidence is very good that any form of
treatment which lowers blood pressure
has a beneficial effect on hypertensive
congestive heart failure. Cardiac failure has fallen from a major cause of
death to a minor cause in adequately
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treated hypertensive patients. In addition, since antihypertensive treatment
is effective in reversing the accelerated
phase of hypertension, it follows that
the transition to the accelerated phase
should be prevented in adequately
treated patients. There also is evidence
that the incidence of cerebral hemorrhage has been reduced. Thus, it appears that antihypertensive therapy is
useful in preventing congestive heart
failure, accelerated hypertension, and
cerebral hemorrhage.
There are as yet no reliable data
to indicate whether antihypertensive
treatment prevents atherosclerotic
complications such as myocardial infarction and cerebral thrombosis. It is
apparent that hypertension accelerates
and aggravates the atherosclerotic
process. Hypertension in some way
predisposes the arterial walls to the
deposition of atherosclerotic plaques.
Atherosclerosis is commonly found in
the pulmonary artery, for example, in
long-standing pulmonary hypertension,
and in the aorta in the region of high
pressure above a coarctation. Once
formed , however, it seems highly unlikely that atherosclerotic plaques
could be influenced by antihypertensive treatment. In addition, we know
that chronic elevation of pressure
leads to structural changes in the arterial walls, including fragmentation
of elastic tissue. It is possible that
these irreversible structural changes
provide a favorable environment for
the development of atherosclerosis
even after the blood pressure has been
reduced. These considerations suggest
that blood pressure must be lowered
in the early stages of hypertension if
antihypertensive treatment is to favorably influence the future course of
atherosclerotic complications.
We have similar evidence that hypertension leads to the structural

changes in the renal arterioles that we
call nephrosclerosis. The rapidity of
development, and the severity of the
nephrosclerotic process, appears to depend on both a persistently high diastolic pressure and a susceptible individual. In the presence of renovascular
hypertension, where a stenosis of one
renal artery is present, producing a
pressure drop across the narrowed
segment, nephrosclerosis develops in
the opposite kidney whose arterioles
are exposed to the high systemic pressure. In the kidney with the pressure
drop, whose arterioles are exposed to
a more normal pressure, nephrosclerosis is minimal or nonexistent. If
nephrosclerosis is to be prevented, this
again suggests that elevated blood
pressure must be lowered at a relatively early stage in the disease.
If there is a relationship between
elevation of blood pressure and atherosclerosis, as well as nephrosclerosis,
then it is reasonable to assume that the
extent of these pathological changes
will depend on both the height and
the duration of the blood pressure. If
the blood pressure is high for only
brief periods of time, and is normal
at all other times, we would not expect
to find vascular pathology. However,
if the pressure is high all of the time,
both day and night, and if this persistently high pressure lasts for many
months or years, then vascular pathology would be expected.
Variability of Blood Pressure Readings

Blood pressure represents a variable
manifestation. It can be strongly influenced by emotion, particularly by
fear and apprehension. There are some
individuals who from childhood manifest transient elevations of blood pressure, associated with apprehension,
who never develop a persistent eleva-
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tion of blood pressure throughout a
normal life span. These individuals
may, ii;i middle and older age, exhibit
pressures of 230/ 130 or even higher
during a visit to a doctor's office or a
clinic, and yet at home their blood
pressure will be -normal. Such hyperresponsiveness may develop in middle
age, particularly in females, or in old
age in both sexes, as was shown by
Pickering almost 30 years ago. These
individuals may show very little organic progression.
Other hypertensive patients exhibit
elevation of blood pressure throughout
the day, whether they are at home or
hospitalized. These patients will almost
all exhibit organic changes, - and the
rate of progression varies in general
with the height of the diastolic blood
pressure.

Predicting the Prognosis of Hypertension and Need for Therapy

Thus, in evaluating hypertensive patients for treatment, we should consider not only the height of the blood
pressure but, more important, its persistence or duration. When we measure blood pressure only in the office or
clinic we should realize that we are
being presented with a mixture of
populations, some of which have severe pressure elevations most of the
time, some with considerably less hypertension than they exhibit in the
office most of the time, and some which
are not hypertensive at all but hyperreact to situations associated with apprehension.
Another way of estimating prognosis is to determine whether organic
changes are already present. We
should utilize the history, the funduscopic examination, the electrocardiogram, chest x-ray, and renal function
tests to estimate the degree of such
damage. Unfortunately, these changes
do not become apparent by ordinary
clinical tests until structural damage is
already well advanced. As pointed out
previously, if antihypertensive treatment can -be expected to produce a
beneficial effect in preventing nephrosclerosis and accelerated atherosclerosis, it should be given in an early
stage of the disease.
It seems evident, therefore, that

physicians should obtain · a more acc~rate estimate of the average blood
pressure than has been customary in
the past. If the office blood pressure is
not a reliable guide, then we should
determine what the blood pressure is
under more representative circumstances. The most representative blood
pressure that is practicably obtainable
is that recorded in the home, not by
the physician but by the patient himself, or better yet, · by a member of his
family. The office nurse can easily and
quickly teach such individuals how to
record blood pressure, and a few manometers can be kept on hand for twoweek loans. The pressure should be
recorded morning and evening for two
weeks in the home and the record
brought to the office on the next
scheduled visit. Frequently, the blood
pressure readings drop immediately or
ov~r a period of days to normotensive
levels. However, the finding of a persistent diastolic elevation above 90
mm of H g is an important criterion for
instituting antihypertensive treatment.
The higher the elevation, the more intensive the treatment will be. Of
course, it is important to make certain
that the blood pressure is being taken
accurately by having the individual
record the pressure in the physician's
presence at the time of the office visit.
Other useful prognostic indices, besides the estimate of the average blood
pressure and the survey for organic
damage, are the age, sex, and race of
the patient, and the rate of progression. These factors are well known
and require no emphasis.
Antihypertensive Drugs

Saluretic Agents (Thiazides); Reserpine
and Hydralazine
In the patient with persistently elevated diastolic blood pressure, but
with little or no signs of organic damage, treatment can begin with an oral
saluretic agent. This generally is not
sufficient by itself to reduce the diastolic pressure to normal. If it is not,
0.5 mg of reserpine twice daily for two
weeks, followed by a maintenance
dose of 0.25 mg once daily can be
added; or else hydralazine (Apresoline) may be added in a dose of 25 mg
two to three times daily. If the latter

is not effective, the dose can be increased gradually to 50 mg three times
daily.
Saluretic agents plus reserpine frequently provide an effective combination therapy in uncomplicated hypertension. The regimen also is convenient
because long-acting diuretics can be
combined with 0.25 mg of reserpine, to
be taken only once daily.
The principal toxic effect of reserpine is mental depression. Generally,
the more intelligent the patient, the
greater the danger of reserpine-induced depression. Unfortunately, other
alkaloids of Rauwolfia are not very
effective as antihypertensive agents
and, therefore, cannot be substituted.
It is important when prescribing reserpine to tell the patient that if he
should begin to feel unaccountably
depressed or to develop sleep disturbances, such as early morning awakening, he should immediately discontinue
the drug. In addition, one should
strive for the lowest possible maintenance dose, which lies between 0.1
mg and 0.25 mg daily in different patients.
The serious toxicity associated with
hydralazine is definitely dose dependent. The chief toxic reaction consists
of a syndrome resembling disseminated lupus which rarely, if ever, occurs when the total daily dose is maintained at 150 mg or less per day. The
acute side effects of hydralazine can
be avoided by a few simple maneuvers.
The first is to add hydralazine to the
regimen of a patient already being
treated with a diuretic or reserpine or
both. The latter two drugs, and particularly reserpine, tend to combat or
neutralize the acute hydralazine side
effects which are headache, palpitation, and tachycardia. The second maneuver is to institute the drug in low
and widely spaced doses, increasing
gradually. For example, hydralazine
can be started in a dose of 25 mg once
daily, increasing in two or three days
to twice daily, and after a similar interval to three times daily. It is surprising how frequently a small dose of
25 mg two or three times daily is effective in uncomplicated hypertension
when it is added to the diuretics with
reserpine, or to reserpine alone. The
trial of hydralazine, however, should
not be abandoned until the dose has
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been increased to 50 mg three times
daily.

Drugs in combination
The results of the large scale doubleblind V.A. Cooperative Study on Antihypertensive Agents clearly showed
the additive effects of these three drugs
in producing a reduction of blood
pressure. The combinations of reserpine and thiazides, or of hydralazinereserpine, or hydralazine-thiazide were
clearly more effective in reducing
blood pressure than any of these
agents used alone. The combination of
all three agents was most effective, reducing the average diastolic blood
pressure to below 90 mm in the patients that had been classified as having hypertension of mild and moderate
severity.
In patients whose blood pressures
are not controlled with any of these
combinations of diuretic-reserpine and
hydralazine, it is advisable first of all
to make certain that you are not being
misled by high office recordings. Patients whose blood pressures are well
controlled at home may completely
overcome the antihypertensive effects
of the drugs in the office or clinic.
Here again a record of home blood
pressures, taken over a two week period, will go far to clarify the situation.
Since the saluretic agents are used so
widely in the treatment of hypertension, it is important to consider their
adverse reactions. The most common
disturbance produced by thiazides is
a reduction in serum potassium levels.
This usually causes no difficulty unless
the patient is receiving digitalis alkaloids, in which case arrhythmias frequently are induced, due to the increased activity of digitalis in the
presence of a reduction in extracellular potassium concentration. Although
it is customary to advise ingestion of
excess potassium in this circumstance,
this cannot be depended upon to raise
the serum potassium level.
Another frequent side effect of thiazide administration is hyperuricemia
due to inhibition of renal tubular secretion of uric acid. In azotemic patients, this frequently precipitates attacks of gout.. It seldom does in
non-azotemic patients. It is advisable
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to control the blood pressure without
thiazides in patients who develop gout.
However, at times the situation demands thiazide treatment. In such a
case probenecid is given to combat the
hyperuricemia and colchicine is administered when necessary to control
symptoms.
Patients with severe renal damage
and acidosis often are unable to conserve salt. If they are placed on salt
restricted diets, and at the same time
are given thiazides, nitrogen retention
may be intensified. The administration of sodium bicarbonate or sodium
lactate to such patients sometimes results in diuresis with a fall in BUN
and in the degree of acidosis.
Diabetes mellitus is occasionally precipitated by thiazides. The incidence
of this complication is low and it is
difficult always to distinguish between
spontaneous diabetes and the drug
induced variety. Finally, thiazides may
induce hypersensitivity reactions with
skin rash and, on rare occasions, thrombocytopenic purpura.

Adrenergic Blocking Agents
If the response to a combination of
diuretic plus low doses of reserpine
and hydralazine truly does not control
the blood pressure, the physician has
the choice of using diuretics plus
adrenergic blocking agents, such as
methyldopa (Aldomet), guanethidine
(Ismelin), or pargyline (Eutonyl).
Orthostatic hypotension poses the
main problem in administering the adrenergic blocking agents. The physician
should be prepared to deal with this
side effect if he is to effectively treat
patients with severe hypertension. The
important points in managing patients
undergoing treatment with the blocking drugs are these:
1) Use saluretic agents in conjunction with blocking drugs whenever
possible. The former tend to smooth
out the large diurnal fluctuations of
blood pressure induced by the blocking agents, and to maintain a more
constant antihypertensive response
from one day to the next. Saluretic
agents also increase the responsiveness
of the blocking agents, permitting
lower doses of the latter.

2) Tell the patient at the time treatment is begun that the drug lowers
the blood pressure in the erect position, that it may reduce it to such a
point that he feels faint, but that the
dose can be adjusted so that this
symptom will not be troublesome.
3) Tell the patient that, if he does
develop weakness or faintness, he is to
discontinue all antihypertensive medications for that day and remain in
bed until the faintness disappears. If
the faintness has disappeared by the
next day, he is to begin again at a
slightly lower dose of the blocking
agent, specifically a decrease of 10 to
20% . If the dose is drastically reduced, the antihypertensive effect will
disappear. The aim, therefore, is to
find the maximum tolerable dose, and
this is frequently just below the one
which produces symptoms of orthostatic hypotension.
4) Tell the patient to be cautious
about drinking alcohol, as the latter
in conjunction with blocking drugs
may induce symptomatic hypotension.
Strenuous exercise also may precipitate orthostatic hypotension.
5) Doses are titrated up to the
effective level. The initial dose is small,
but it is increased gradually until an
antihypertensive effect or symptoms of
orthostatic hypotension occur.
6) Reassure the patient that if orthostatic faintness or syncope occurs, it
is not as serious as it seems; that it is
equivalent to an ordinary faint, and
that it can be avoided by proper regulation of dosage.
7) If the patient complains of orthostatic faintness, particularly in the
morning, and if the office blood pressures are still elevated without a fall
on standing, it may be either that the
orthostatic effect disappears in the
afternoon or evening, or else that the
office recordings are abnormally elevated due to apprehension. If possible,
the patient should visit the office in
the morning when pressures are usually the lowest. Best of all is to have
twice daily recordings taken in the
home by a member of the family or
the patient himself. Home blood pressure recordings are an invaluable adjunct in the treatment of severe hypertensive patients whose blood pressure
levels are difficult to control.
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Relative Merits of Methyldopa, Guanethidine, and Pargyline
Methyldopa is well tolerated because it produces less severe orthostatic hypotension and does not usually interfere with sexual function. It
also depresses renal function less than
guanethidine in patients with renal
failure. On the other hand, it is effective in controlling blood pressure in
only about half ot the patients with
severe hypertension. Three to four
doses per day are required as compared to only one dose per day of the
other blocking agents; it occasionally
produces fever and hepatitis, and it is
more expensive than the other drugs.
Methyldopa is begun in a dose of 250
mg three times daily, increasing as
necessary to a level of 750 mg four
times daily. Elevations beyond this
level generally produce little additional
antihypertensive effect. The most fre~uent side effect is drowsiness, which
1s usually transient, tending to disappear after a stable dose level has
been maintained for several weeks.
. Guanethidine or Ismelin is begun
~n a dose of 10 mg once daily, and is
mcreased every week by 10 mg until
orthostatic hypotension or a reduction
in supine pressure appears. In hospitalized patients or in those with severe hypertension, the doses can be
raised more rapidly. The maximum
dose is about 200 mg daily, although
most patients will exhibit an antihypertensive effect in the range of 25 to 75
mg when thiazides are given adjunctively.
Guanethidine probably lowers blood
~ressure .in a greater percentage of patients with severe hypertension than
does any other drug. Dosage also is
co~venient since the total daily reqm~eme~t can be taken once daily in
coniunction with a long-acting saluretic
agent. No hypersensitivity reactions
or serious organ toxicity have been observed. Because it is a potent blocking
agent, it is capable of inducing profound orthostatic hypotension. Once
the dose is regulated, however, patients
generally are not disturbed by this side
effect. Diarrhea may be troublesome
and usually calls for a slight reduction
in dose. Atropine-like compounds, as
well as paregoric, also can be used to
combat this side reaction. While under

the influence of adrenergic blockade
impotence occurs because orgasm i~
associated with ejaculation into the
urinary bladder.
Another blocking agent in current
use is pargyline or Eutonyl. Effective
doses vary widely from as little as 10
mg to as much as 100 mg per day. If
the latter dose is ineffective, larger
amounts generally will not be effective.
Pargyline is a monamine oxidase inhibitor and "psychic energizer." It
does produce increased alertness and
drive, sometimes to the point of inducing insomnia. Severe orthostatic hypotension can occur even in low doses.
The onset of this latter effect may be
delayed for several weeks or longer.
For this reason, the doses should be
gradually elevated with increases at
widely spaced intervals several weeks
apart.
Patients taking monamine oxidase
inhibitors may develop severe and even
fatal hypertensive responses following
the ingestion of processed cheese. This
unusual side effect is thought to be
due to tyramine which is present in
cheese.
It can be seen from this brief review that all antihypertensive agents
are potentially toxic. The decision to
treat a given patient, therefore, should
not be undertaken lightly. To the risk
of toxicity must be added the inconvenience and expense involved in lifelong treatment. An assessment of the
average blood pressure and the extent
of organic damage already present will
help in separating those patients who
require no treatment, and in determining in the remainder how intensive the
therapeutic program need be. The
deat~ rates from hypertension, hypertensive heart disease, and cerebral
hemorrhage appear to have been strikingly reduced since the advent of antihypertensive drug treatment. Therefore, this note of caution is not meant
to discourage the application of antihypertensive agents, but rather to advocate care and discrimination in their
use.
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